127 related articles for article (PubMed ID: 20800346)
1. Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene.
Shimizu H; Oka N; Kawarai T; Taniguchi K; Saji N; Tadano M; Bernardi G; Orlacchio A; Kita Y
Clin Neurol Neurosurg; 2010 Nov; 112(9):798-800. PubMed ID: 20800346
[TBL] [Abstract][Full Text] [Related]
2. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
3. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.
Laurà M; Milani M; Morbin M; Moggio M; Ripolone M; Jann S; Scaioli V; Taroni F; Pareyson D
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1263-6. PubMed ID: 17940173
[TBL] [Abstract][Full Text] [Related]
4. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype.
De Jonghe P; Timmerman V; Ceuterick C; Nelis E; De Vriendt E; Löfgren A; Vercruyssen A; Verellen C; Van Maldergem L; Martin JJ; Van Broeckhoven C
Brain; 1999 Feb; 122 ( Pt 2)():281-90. PubMed ID: 10071056
[TBL] [Abstract][Full Text] [Related]
5. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
6. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia.
Luigetti M; Modoni A; Renna R; Silvestri G; Ricci E; Montano N; Tasca G; Papacci M; Monforte M; Conte A; Pomponi MG; Sabatelli M
Clin Neurol Neurosurg; 2010 Nov; 112(9):794-7. PubMed ID: 20537790
[TBL] [Abstract][Full Text] [Related]
7. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene.
Chapon F; Latour P; Diraison P; Schaeffer S; Vandenberghe A
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):779-82. PubMed ID: 10329755
[TBL] [Abstract][Full Text] [Related]
8. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met.
Senderek J; Hermanns B; Lehmann U; Bergmann C; Marx G; Kabus C; Timmerman V; Stoltenburg-Didinger G; Schröder JM
Brain Pathol; 2000 Apr; 10(2):235-48. PubMed ID: 10764043
[TBL] [Abstract][Full Text] [Related]
9. Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family.
Leal A; Berghoff C; Berghoff M; Del Valle G; Contreras C; Montoya O; Hernández E; Barrantes R; Schlötzer-Schrehardt U; Neundörfer B; Reis A; Rautenstrauss B; Heuss D
Neurogenetics; 2003 Aug; 4(4):191-7. PubMed ID: 12845552
[TBL] [Abstract][Full Text] [Related]
10. Novel C59T leader peptide mutation in the MPZ gene associated with late-onset, axonal, sensorimotor polyneuropathy.
Finsterer J; Miltenberger G; Rauschka H; Janecke A
Eur J Neurol; 2006 Oct; 13(10):1149-52. PubMed ID: 16987171
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic clustering in MPZ mutations.
Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease.
Santoro L; Manganelli F; Di Maria E; Bordo D; Cassandrini D; Ajmar F; Mandich P; Bellone E
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):262-5. PubMed ID: 14742601
[TBL] [Abstract][Full Text] [Related]
13. Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene.
Auer-Grumbach M; Strasser-Fuchs S; Robl T; Windpassinger C; Wagner K
Neurology; 2003 Nov; 61(10):1435-7. PubMed ID: 14638973
[TBL] [Abstract][Full Text] [Related]
14. Dysmyelinating and demyelinating Charcot-Marie-Tooth disease associated with two myelin protein zero gene mutations.
Drac H; Kabzińska D; Moszyńska I; Strugalska-Cynowska H; Hausmanowa-Petrusewicz I; Kochański A
J Appl Genet; 2011 May; 52(2):177-83. PubMed ID: 21107784
[TBL] [Abstract][Full Text] [Related]
15. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.
Fabrizi GM; Tamburin S; Cavallaro T; Cabrini I; Ferrarini M; Taioli F; Magrinelli F; Zanette G
Clin Neurophysiol; 2018 Jan; 129(1):21-32. PubMed ID: 29136549
[TBL] [Abstract][Full Text] [Related]
17. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val).
Misu K; Yoshihara T; Shikama Y; Awaki E; Yamamoto M; Hattori N; Hirayama M; Takegami T; Nakashima K; Sobue G
J Neurol Neurosurg Psychiatry; 2000 Dec; 69(6):806-11. PubMed ID: 11080237
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation in the
Kozina AA; Baryshnikova NV; Ilinskaya AY; Kim AA; Plotnikov NA; Pogodina NA; Surkova EI; Shatalov PA; Ilinsky VV
J Int Med Res; 2022 Dec; 50(12):3000605221139718. PubMed ID: 36567457
[TBL] [Abstract][Full Text] [Related]
19. Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation.
Prada V; Capponi S; Ursino G; Alberti A; Callegari I; Passalacqua M; Marotta R; Mandich P; Bellone E; Schenone A; Grandis M
Neuropathology; 2015 Jun; 35(3):254-9. PubMed ID: 25388615
[TBL] [Abstract][Full Text] [Related]
20. Late onset axonal Charcot-Marie-Tooth phenotype caused by a novel myelin protein zero mutation.
Bienfait HM; Faber CG; Baas F; Gabreëls-Festen AA; Koelman JH; Hoogendijk JE; Verschuuren JJ; Wokke JH; de Visser M
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):534-7. PubMed ID: 16543539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
